Wearable Injectors are those devices/patches that are capable of storing a large volume of drugs and allow you to conveniently take high-volume medication. These patches are designed to stick to the body and meanwhile, the drug is delivered to the patient simultaneously. Wearable injectors are the next big step in the healthcare sector as the injectors will ease the intake of medications by delivering drugs directly to the tissues of the body. The wearable injectors are of two types “in-body” and “off-body” wearable injectors. The best part about these devices is that they deliver the preset doses to the patients at an optimal time and are user-friendly, disposable, cause less pain and discomfort, are far better than syringes & vials, and are built-in for single use only. After the completion of the dose, very conveniently they are removed from the body and decomposed. Wearable injectors are widely used in diseases such as cardiovascular diseases, cancer, rheumatoid arthritis, neurological disorder, and chronic diseases such as diabetes. Medical sciences are touching new heights and offering people new and advanced treatment options so that they can perform their daily tasks such as being active at work, going to parties, or any wedding, and wearable injectors prove to be a boon.

Technical advancements in the healthcare industry such as digital displays and Bluetooth connectivity with smartphones are vigorously augmenting the market growth. Also, an increase in the use of biologics, a hike in the chronic, cancer & cardiovascular diseases globally, rising geriatric population, an upsurge in the investments in the healthcare industry, and growing demand for personalized & home-based treatment facilities are driving the growth of the wearable injectors market.

However, the high costs associated with the injectors, lack of proper healthcare infrastructure & treatment facilities; especially in the developing regions, and high risks of side effects are hindering the market growth.

Furthermore, extensive ongoing R&D projects and support from the government and various corporate sectors are providing lucrative opportunities to the global wearable injectors market. Additionally, the key players are investing in the market and adopting strategies such as partnerships, collaborations, and product development to provide better opportunities in the market.

Enable Injections, United Therapeutics (Steadymed Therapeutics, Inc.), Insulet Corporation, Medtronic PLC, Sensile Medical Ag, West Pharmaceutical Services, Inc., Becton Dickinson and Company, Buhler Motor Gmbh, Ypsomed, and Eoflow, among others are the prominent players of the global wearable injectors market.